Cure for CLL?

Research output: Contribution to journalArticle

3 Scopus citations

Abstract

In this issue of Blood, Thompson et al present their exciting long-Term results with the use of fludarabine, cyclophosphamide, and rituximab (FCR) chemoimmunotherapy in patients with previously untreated chronic lymphocytic leukemia (CLL).1.

Original languageEnglish (US)
Number of pages1
JournalBlood
Volume127
Issue number3
DOIs
Publication statusPublished - Jan 21 2016
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Cite this